FIRE1

Description

FIRE1 develops NORM, an investigational heart failure management system that combines an implanted sensor in the inferior vena cava with a daily belt-and-phone routine for home monitoring, heart-status tracking, and clinician alerts.

FIRE1 is located in the Dublin ecosystem.

Related

• FineHeartFineHeart develops FlowMaker as a therapy for advanced heart failure, creates clinical-stage cardiology technology, and leads an IPCEI…
• CroíValveCroíValve develops the DUO Adapt™ System, a minimally invasive transcatheter heart valve device for treating tricuspid regurgitation in…
• Novus DiagnosticsNovus Diagnostics builds a rapid point-of-care diagnostic platform using microfluidic electrochemical sensors and diagnostic algorithms for…
• NeuromodNeuromod develops and commercializes Lenire, a bimodal neuromodulation medical device for treating tinnitus, supplying clinicians and…
• ATXA TherapeuticsATXA Therapeutics develops selective small-molecule thromboxane receptor (TP) antagonists, including lead candidate NTP42, to treat…
• CorWaveCorWave develops an implantable left ventricular assist pump that uses a wave membrane to produce truly pulsatile blood flow for treating…
• CAREPOI®CAREPOI® creates cloud-native AI healthcare intelligence and telemedicine platforms that link patients, clinicians, diagnostics, and…
• AnaCardioAnaCardio develops novel inotropic drugs that act via the ghrelin signalling pathway to increase cardiomyocyte contractility and cardiac…
• Powerful MedicalPowerful Medical builds PMcardio, an AI ECG platform that detects acute heart attacks and estimates left ventricular function for…